Studies have shown that patients critically ill with COVID-19 have higher serum concentrations of proinflammatory cytokines and chemokines, including granulocyte colony-stimulating factor, monocyte chemoattractant protein-1, TNF-α, IL-6 and IL-1β, than healthy individuals [24,67]. This evidence concerns the gene CCL2 and COVID-19.